Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis

Current Eye Research

Volumn 29, Issue 4-5, 2004, Pages 253-259

  Pollack, John S ^a   Beecher, Douglas J ^b   Pulido, Jose S ^c   Wong, Amy C Lee ^d  

^a Illinois Retina Associates   (United States)

^b FBI LABORATORY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bacillus cereus; Dexamethasone; Endophthalmitis; Exotoxins; Intraocular inflammation

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BACILLUS CEREUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; ENDOPHTHALMITIS; EXPERIMENTAL MODEL; EYE TOXICITY; HISTOPATHOLOGY; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RABBIT; RETINA NECROSIS; RETINITIS; SCORING SYSTEM; STEROID THERAPY; TREATMENT FAILURE; VITRECTOMY;

ANIMALS; BACILLUS CEREUS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; GLUCOCORTICOIDS; GRAM-POSITIVE BACTERIAL INFECTIONS; INFLAMMATION; INJECTIONS; NECROSIS; RABBITS; RETINA; VITREOUS BODY;

EID: 11844277673     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490516701     Document Type: Article

References (25)

1. Foster RE, Martinez JA, Murray TG, Rubsamen PE, Flynn Jr. HW, Forster RK. Useful visual outcomes after treatment of Bacillus cereus endophthalmitis. Ophthalmology. 1996;103:390-397.
2. Greenwald MJ, Wohl LG, Sell CH. Metastatic bacterial endophthalmitis: A contemporary reappraisal. Surv Ophthalmol 1986;31:81-101.
3. Vahey JB, Flynn HW, Jr. Results in the management of Bacillus endophthalmitis. Ophthalmol Surg. 1991;22:681-686.
4. Beer PM, Ludwig IH, Packer AJ. Complete visual recovery after Bacillus cereus endophthalmitis in a child. Am J Ophthalmol. 1990;110:212-213.
5. Jett BD, Parke DW, Booth MC, Gilmore MS. Host/parasite interactions in bacterial endophthalmitis. Zbl Bakt. 1997;285:341-367.
6. Barletta JP, Small KW. Successful visual recovery in delayed onset Bacillus cereus endophthalmitis. Ophthal Surg Lasers. 1996;27:70-72.
7. Beecher DJ, Pulido JS, Barney NP, Wong ACL. Extracellular virulence factors in Bacillus cereus endophthalmitis: Methods and implication of involvement of hemolysin BL. Infect Immun. 1995;63:632-639.
8. Beecher DJ, Olsen TW, Somers EB, Wong ACL. Evidence for contribution of tripartite hemolysin BL, phosphatidylcholine-preferring phospholipase C, and collagenase to virulence of Bacillus cereus endophthalmitis. Infect Immun. 2000;68:5269-5276.
9. Callegan MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun. 2000;67:3348-3356.
10. Callegan MC, Scott TK, Cochran DC, Gilmore MS, Gominet M, Lereclus D. Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect Immun. 2003;71:3116-3124.
11. Parke DW, Brinton GS. Endophthalmitis. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye. Boston, MA: Little, Brown, and Co.; 1986:563-585.
12. Levin MR, D'Amico DJ. Traumatic endophthalmitis. In: Shingleton BJ, Hersh PS, Kenyon KR, eds. Eye Trauma. St. Louis, MO: Mosby Year Book; 1991:242-252.
13. Meredith TA, Aguilar HE, Drews C, Sawant A, Gardner S, Wilson LA, Grossniklaus HE. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc. 1996;94:241-252.
14. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin non-producing Entercoccus faecalis strains. Invest Ophthalmol Vis Sci. 1995;36:9-15.
15. Aguilar HE, Meredith TA, Drews C, Grossniklaus H, Sawant AD, Gardner S. Comparative treatment of experimental Staphylococcus aureus endophthalmitis. Am J Ophthalmol. 1996;121:310-317.
16. Park SS, Samiy N, Ruoff K, D'Amico DJ, Baker AS. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol. 1996; 113:1324-1329.
17. Meredith TA, Aguilar HE, Miller MJ, Gardner SK, Trabelsi A, Wilson LA. Comparative treatment of Staphylococcus epidermidis endophthalmitis. Arch Ophthalmol. 1990;108: 857-860.
18. Liu SM, Way T, Rodrigues M, Steidl SM. Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Arch Ophthalmol. 2000;118:803-306.
19. Metrikin DC, Wilson CA, Berkowitz BA, Lam MK, Wood GK, Peshock RM. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis. Invest Ophthalmol Vis Sci. 1995;36:1361-1370.
20. Jacobs DR, Cohen HB. The inflammatory role of endotoxin in rabbit gram-negative bacterial endophthalmitis. Invest Ophthalmol Vis Sci. 1984;25:1074-1079.
21. Csukas S, Paterson CA, Brown K, Bhattacherjee P. Time course of rabbit ocular inflammatory response and mediator release after intravitreal endotoxin. Invest Ophthalmol Vis Sci. 1990;31:382-387.
22. Kwak HW, D'Amico DJ. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol. 1992;110:259-266.
23. Beecher DJ, Wong ACL. Improved purification and characterization of hemolysin BL: A hemolytic dermonecrotic vascular permeability factor from Bacillus cereus. Infect Immun. 1994;62:980-986.
24. Callegan MC, Jett BD, Hancock LE, Gilmore MS. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect Immun. 1999;67:3357-3366.
25. Beecher DJ, Wong ACL. Tripartite haemolysin BL: Isolation and characterization of two distinct homologous sets of components from a single Bacillus cereus isolate. Microbiology. 2000;146:1371-1380.